SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-013555
Filing Date
2021-03-25
Accepted
2021-03-25 20:13:51
Documents
2
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4038
2 EX-24 DOCUMENT attachment1.htm EX-24 4698
  Complete submission text file 0000899243-21-013555.txt   10105
Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Santillana Sergio L. (Reporting) CIK: 0001708767 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40287 | Film No.: 21774240

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Issuer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)